Lung Fung Group Holdings Limited filed its Monthly Return for Equity Issuer with the Hong Kong Stock Exchange for the period ended 30 September 2026, indicating a stable share-capital structure and full compliance with public-float requirements.

Authorised and issued share capital • Authorised share capital remained unchanged at 3.90 billion ordinary shares with a par value of HKD 0.0001 each, equivalent to HKD 390,000.

• Issued share capital was steady at 500.00 million ordinary shares, with no treasury shares on record, leaving total issued shares also at 500.00 million.

Public-float status • The company confirmed that it met the Main Board’s minimum public-float threshold of 25% as at 30 September 2026.

Corporate governance statement • The filing, signed by Company Secretary Lam Yin Ling on 5 October 2026, states that all applicable listing rules and regulatory requirements were satisfied during the month, with no share options, warrants, convertibles, or other equity instruments issued or outstanding movements recorded.

Overall, Lung Fung Group’s equity structure and regulatory posture remained unchanged throughout September 2026, underscoring capital stability and ongoing compliance with Hong Kong listing obligations.